Drug and Alcohol Problems Linked to Vet Suicides, Especially in Women

Veterans already have an increased risk of suicide. Those with substance use disorders or mental health conditions are in particular need of help, a new study asserts.

9:00 AM

Author | Kara Gavin

Veterans who have drug or alcohol problems are more than twice as likely to die by suicide as their comrades, a new study finds. And women veterans with substance use disorders have an even higher rate of suicide — more than five times that of their veteran peers, the research shows.

MORE FROM THE LAB: Subscribe to our weekly newsletter

The risk of suicide differs depending on the type of substance the veteran has problems with, according to the study.

The highest suicide risks are among those who misuse prescription sedative medicines, such as tranquilizers. Female veterans who misuse opioid drugs also have an especially high risk of suicide, according to the study.

The research, published in the journal Addiction by a team from the University of Michigan and the U.S. Department of Veterans Affairs, finds that much of the difference in suicide risk lies with veterans who have both mental health conditions and substance use issues.

The new findings, the researchers say, underscore a need to focus more veteran suicide prevention efforts on those with substance use disorders, especially for individuals with depression, schizophrenia, bipolar disorder, post-traumatic stress disorder or anxiety.

The study used data from more than 4.4 million veterans, one of the largest-ever examinations of substance use disorders and suicide.

"We hope these findings will help clinicians and health systems care for people with substance use disorders, with mental health conditions, and with both — and focus suicide prevention efforts accordingly," says Kipling Bohnert, Ph.D., lead author of the study and researcher with the VA Center for Clinical Management Research who is also an assistant professor of psychiatry at the U-M Medical School. "Substance use disorders may be important markers for suicide risk."

Twenty U.S. veterans die by suicide each day, according to the Department of Veterans Affairs. That's a much higher rate than in the general population.

Because two-thirds of the suicides examined in the study involved firearms, the researchers also note that firearm safety is important in efforts to reduce the toll of suicide on those who have served the nation. In addition, one-quarter of suicides among veterans with substance use disorders were by intentional poisoning, highlighting the need for preventive strategies targeted to this group. 

The researchers say their work may have implications for the civilian population as well, but note that it's harder to study individuals outside the VA because records aren't centralized in the same fashion.

About the study

Using VA funding, Bohnert and his colleagues from the Department of Veterans Affairs, the U-M Addiction Center and the U-M Institute for Healthcare Policy and Innovation looked at VA records from a large group of veterans who saw a VA provider in 2004 and 2005. They then tracked suicides among this group over the next six years.

SEE ALSO: Health on the Homefront: Efforts to Improve Civilian Care for Veterans

In all, 8.3 percent of men and 3.4 percent of women in the cohort had a substance use disorder recorded in their list of diagnoses in 2004-2005. And 9,087 of the veterans in the study group died by suicide during the follow-up years.

Using statistical techniques, the team calculated suicide rates per 100,000 person-years, and then calculated those rates for veterans with substance use issues overall, and then for specific substance use disorders.

In all, the suicide rate was 75.6 per 100,000 person-years with any substance use disorder; the rate for veterans overall was much lower — 34.7 per 100,000 person-years. A previous study led by Mark Ilgen, Ph.D., also co-author on the new study, found similarly higher rates among veterans who were tracked from 1999 to 2006.

But the new study lets the researchers drill down to the specific substance that veterans had problems with, including alcohol, opioids, marijuana and cocaine.

The study found the suicide rate was highest for veterans of both genders who misused sedatives — 171.4 per 100,000 —  and markedly higher for women who misused opioids, at 98.6 per 100,000. The researchers couldn't distinguish between misuse of prescription opioids and problems with other nonprescription opioids, such as heroin.

Male veterans who misused amphetamines also had a suicide rate of 95 per 100,000. The study couldn't tell whether they were misusing prescription amphetamines, such as those used for attention deficit disorder, or using illicit drugs such as methamphetamine.

The researchers then took into account veterans' ages and the overall severity of their medical conditions, and calculated the risk of suicide by type of substance use disorder.

This reduced the size of the difference in suicide risks somewhat, but most of the original relationships remained. When the researchers factored in mental health diagnoses, the picture changed. Among women, only alcohol and opioid disorders remained associated with higher suicide risk, independent of mental and physical health. Differences between men and women diminished as well.

But both genders with substance use disorders had a higher rate of suicide even after differences in physical and mental health were factored in. 

In all, says Bohnert, "Assessment and treatment of coexisting psychiatric conditions, in addition to substance use, may be important in lowering the risk of suicide among individuals who have substance use disorders."


More Articles About: Rounds Addiction and Mental Illness Depression Post Traumatic Stress Disorder (PTSD) Soldiers and War veterans Addiction and Substance Abuse
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of healthcare news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories Illustration of girl with blue water line, depicting a figure drowning, as girl contemplates pill in hand
Health Lab
Antidepressant dispensing to adolescents and young adults surges during pandemic
Rate of antidepressant dispensing to young people rose faster after March 2020, especially among females
Breaking Down Mental Health on blue background and text inside a yellow head graphic
Breaking Down Mental Health
Suicide Within Depression
In this episode, learn to understand misconceptions about depression and suicide and differentiate the importance of assessing for suicidality and depression separately.
Breaking Down Mental Health on blue background and text inside a yellow head graphic
Breaking Down Mental Health
Treatment Resistant Depression
In this episode, learn to define electroconvulsive therapy, and its risks, benefits, and rationale for treatment modality and transcranial magnetic stimulation, and its risks, benefits, and rationale for treatment modality.
Breaking Down Mental Health on blue background and text inside a yellow head graphic
Breaking Down Mental Health
Psychotropic Medications for Depression
In this episode, learn to identify appropriate selective serotonin reuptake inhibitors for the management of depression in pediatric patients and how they work and identify appropriate serotonin-norepinephrine reuptake inhibitors for the management of depression in pediatric patients and how they work.
Breaking Down Mental Health on blue background and text inside a yellow head graphic
Breaking Down Mental Health
Depression and Sleep
In this episode, learn to understand the interplay between depression and how cognitive behavioral therapy can improve sleep.
Breaking Down Mental Health on blue background and text inside a yellow head graphic
Breaking Down Mental Health
Pediatric Depression
In this episode, learn to differentiate between depression presentation in children versus adults and determine appropriate screening tools for depression for the screening of children and adolescents.